MAPT and Alzheimer disease: Elevated levels of amyloid β and tau phosphorylation in brain and other AD-related molecular and cellular alterations, such as mitochondrial dysfunction, synaptic deficits, impaired neurite growth, neuronal cell death, glial cell activation, neuroinflammation, neurovascular dysfunction, and increased oxidative stress are observed [30].